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Balloon-expandable stents were placed successfully in 35
(95%) of 37 patients whose right coronary artery lesion was
believed to have a poor short. or long-term prognosis with
conventional balloon angioplasty because of prior restenosls
or adverse Lesion morphology. Quantitative angiogaphy
showed a reduction in atenosis diameter from 83 t 14% to
42 t 14% after conventional balloon dilation, with a
further reduction to -3 t 12% after scent placement (p <
0.001). There were no acute Scent thromboses, but one
patient (with two stems and unscented distal disease) devel-
oped subacute thrombosis on day 8 after self-dtuootinua .
lion of warfarin and was treated with thrombolytie therapy
and reduction .
Follow-up angiography was performed at 4 to 6 months
Despite progressive improvement in conventional balloon
equipment and technique. coronary angioplasty continues to
be plagued by difficulties in dilating eccentric lesions
. avoid-
ing or reversing abrupt closure of the dilated segment
(resulting from extensive local dissection) and preventing or
definitively treating restenosis of the dilated segment
. lntra-
coronary stents are one of the new technologies that (along
with atherectomy and iaser/laser thermal techniques) have
recently entered clinical testing with the goal of providing a
practical and predictable solution to these difficulties (1). As
one of 10 centers investigating the use of such a device
(Schatz-Palmaz scent, Johnson & Johnson), we had the
opportunity to attempt placement of balloon-expandable
metallic stents in 37 patients from June 1988 through Sep-
tember 1989 .
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in 25 patients, demonstrating restenosls (83 t 13%) In 4
(57%) of 7 patients with multiple scents, but only 3 (17%) of
18 patients with a single stent (p < 0 .05), Six of the seven
in-stem restenotle lesions were subtotal (80 cx 12%) and
were subjected to repeat conventional balloon angioplasty
(postdlation stenosis 13 t 21%1. The 18 patients without
restenosis had a maximal in.stent diameter stenosis of 29 ±
15%, corresponding to a maximal focal neeintimal thick-
ness of 0.68 x 0,26 mm within the stented segment. These
preliminary results suggest that the SehataPatmaa stent
may be a useful adjunctive device in the performance of
coronary angioplasty .
(J Am Coll Candid 1990;16:332-9)
Methods
Study patients. Stent candidates were drawn from 860
patients who underwent angioplasty during the study period
and were selected for anatomic or clinical factors, or both,
that were believed to predict poor short- or long-term
outlook with conventional balloon techniques . These factors
included restenosis after conventional balloon angioplasty
(21 patients [57% . 11 with one and 10 with two or more
previous angioplasty procedures]) or adverse lesion charac-
teristics (marked eccentricity [i7 patients, 46%] . flaplike or
ulcerated lesions [5 patients, 14%] or total occlusion [2
patients, 5%])
.
Because of institutional preferences in selecting among
several new technologies for coronary intervention and
limitations relating to the delivery of both the initial rigid
stent (Patients 1 to 7) and the subsequent flexible or "artic-
ulated" design, we chose to restrict stent placement in this
series to a right coronary artery without marked proximal
tortuosity. Based on protocol, patients were also selected for
the presence of baseline or recruitable collateral vessels to
the distal vessel. The study group consisted of 27 men and 8
women (average age 57 ± 11 years).
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Figure 1. Right coronary restenosis treated with a
rigid stent. A markedly eccentric restenotic lesion
after previous balloon angioplasty is shown before
(tar left) and after tuft center) conventional balloon
angioplasty, immediately after stem placement (right
center). Six month restudy (far right) shows moder-
ate fusiform intimal hyperplasia (maximal intimal
thickness .73 mm, stenosis 27%) . The rigid dent is
shown (lower panel) before and after balloon infla-
tion.
Slent placement. In each case, conventional balloon an-
gioplasty of the target lesion was performed before at-
tempted stent placement . After achieving a satisfactory
conventional result (reduction in stenosis by ?2 % with a
residual stenosis <5 %), we attempted to place one or more
15 mm long stems to cover the dilated segment .
In the first seven procedures, the stent consisted of a
rigid, slotted steei rube 15 mm in length and 1 .6 mm in
diameter, with a wall thickness of . 3 in . ( . 8 mm) (Fig. 11
(2,3)
. Because this device cannot be passed through the
bends found in conventional guiding catheters, it was
mounted On a delivery balloon (Trac-Plus. Scimed Life
Systems) that had been advanced to beyond the tip of a large
lumen guiding catheter (9F hockey stick or modified left
Amplatz, Interventional Medical) . After the scent was firmly
crimped onto the delivery balloon . the stent balloon assem-
bly was withdrawn into the relatively straight tip of the
guiding catheter, and the entire system was introduced
through the femoral artery sheath, The guiding catheter was
engaged in the right coronary ostium, and the stent balloon
assembly was advanced down the artery and across the
target stenosis over a . 14 in. ( .36 mm) guide wire (high
torque floppy, Advanced Cardiovascular Systems) . When in
position, the slept was deployed by a single 2 s balloon
inflation to 6 psi (4 aim) .
In the remaining .3 procedures, the modified design of
Schatz (2) was
employed . i
n which the stent is "articulated"
and consists of two rigid segments (each 7 mm in length)
joined by a flexible bridge (I mm in length) . all etched from
a single steel tube . Unlike its rigid predecessor, the articu-
lated stent can be crimp-mounted on a high profile balloon
(LPS, USCII and advanced through a standard guiding
catheter (fight Judkins or left Amplatz, Shiley) over a . 14
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in. ( .36 mm) exchange length guidewire. This obviated the
need to recross the tat¢et stenosis with the guide wire after
conventional predilation, although stem delivery was other-
wise identical .
Tile overage balloon size used for prestent conventional
angioplasty was 3.1 ± .4 mm and the average initial stent
delivery balloon size was 3.2 ± .3 mm (2.5 in 2 patients. 3
in 15 patients. and 3.5 mm in 19 patients) . In 18 of 35 patients
who underwent successful stent placement (including I
patient with two differently sized stunts), the initial stem
delivery balloon was then exchanged for a larger balloon
catheter (average size 3 .5 ± .4 mm) to further expand the
stent to a final size of 3 (9 patients) . 3 .5 (16 patients) or 4 mm
(1 patients)
.
Concomitant medical therapy. Because of the known
thrombogenicity of intracoronay endoprostheses (2,3), all
patients were pretreated (>_24 h) with aspirin (325 mg day)
and dipyridamole (2 mg day) . A I liter infusion of low
molecular weight dextran (Dextean 4 . 1 mllh) was begun
3 h before stent placement and continued for a total of 1 h.
An initial heparin bolus injection (1 , U) was adminis-
tered intravenously just before the conventional angioplasty
and supplemented (usually with 2,5 U 3
min) to maintain
an activated clotting time (ACT, HemoTech) of between 25
and 3
s
. Heparin infusion was then continued (1, U h)
overnight until removal of the arterial sheath .
1a the initial 18 patients . long-term anticoagulant therapy
was limited to aspirin and dipyridamole (for 6 months),
unless there was unstented distal disease dissection or mul-
tiple stems were placed (six patients with these findings had
warfarin added to aspirin and dipyridamole to maintain a
prothrombin time of 16 to 18 s for 3 months after stent
implantation), In the subsequent 17 patients, aspirin and
334
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dipyridamole for 6 months) and warfarin (for 3 months)
were administered empirically, with continuation of the
heparin infusion until a therapeutic prothrombin time was
achieved .
Given the potentially devastating consequences of a
prosthesis-related infection, all patients received prophylac-
tic intravenous antibiotic therapy (cephazolin, I g18 h),
starting just before scent placement and continuing for 4B h
.
Oral antibiotic prophylaxis was administered for dental work
performed within 3 months of stent placement, by which
time endothelialization was considered to be complete .
Follow-up protocol . Each patient underwent clinical fol-
low-up study, including a symptom-limited exercise toler-
ance test at 1, 3 and 6 months
. Repeat coronary angiography
was carried out between 4 and 6 months (mean 5 ± I) after
stem placement in 25 (83%) of the 31 patients who had
reached the time window for repeat catheterization .
Analysis of augiographic results . Each treated lesion was
evaluated in a single matched "worst view" using digital
calipers (Sandhill Instruments) referenced to the known
diameter of the guiding catheter (4) . Measurements included
luminal diameter before balloon angioplasty, after conven-
tional angioplasty and after stem placement, as well as the
diameter of the adjacent reference segment
.
Follow-up angiograms
were performed with 2 s of filming
before contrast injection to optimally identify the scent
shadow . Films were evaluated (Fig . 2) for stem diameter
(outer diameter of the metallic shadow), minimal and aver-
age luminal diameter within the stented segment and diam-
eter of the adjacent reference segment . Maximal focal inti-
mal thickness was estimated as half the difference between
the measured went diameter and the minimal luminal diam-
eter within the stent . A background-generalized intimal
thickness was also calculated by comparing the average
luminal diameter within the stunt with the diameter of the
metallic stent itself .
In-srent diameter stenosis
was calculated comparing the
minimal luminal diameter with that of the adjacent reference
segment. Patients with a stenosis ?6 % anywhere within or
immediately adjacent to the stented segment were consid-
ered to have restenosis, even in the absence of objective
evidence of regional ischemia .
Statistical analysis
. Group data were expressed as mean
values ± SD . Data from the quantitative angiographic anal-
ysis before and after balloon angioplasty and after stunting
were compared with the Friedman two-way analysis of
variance (ANOVA). Chi-square analysis was used to evalu-
ate differences between groups .
Results
Clinical results of steal placement
. Stent placement was
successful in 35 (95%) of the 37 vessels
. Twenty-seven of the
35 patients underwent placement of a single scent, 7 under-
PRE-PTCA
r•_•_ NIT I
POST-STENT
RESTUDY
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Figure 2. Schematic diagram of the measurements made during
acute stunt placement and follow-up angiography . Immediately after
(POST) stem placement Imiddle panel) measurements include lumi-
nat diameter within the stem (d) and luminal diameter within the
reference segment Ir). At 4 to 6 month follow-up study (lower panel),
measurements include outer diameter of stunt (s), minimal luminal
diameter(d.„),
generalized luminal diameter within the stent (d„,)
and diameter of the reference segment
(r)
. Maximal and generalized
neointimal thickness are calculated by comparing stunt diameter
with the minimal and general luminal diameter, respectively (see
text) . PRE = before: PTCA = balloon angioplasty.
went placement of two stents and I underwent placement of
four stems (for extensive dissection after conventional bal-
loon angioplasty of a markedly eccentric lesion) . When
multiple stems were inserted, placement of the most distal
stunt was attempted first, but in three cases, it was necessary
to place the proximal stem first before an additional stent or
stents could be placed (stunt through stent) to cover the
more distal diseased segment . The mean procedure time
(from local anesthesia to completion) was 78 ± 21 min.
Of the nvo failed stem
placements (one rigid and one
articulated), failure resulted from inability to pass the stent
across the lesion . The rigid stem embolized into the pelvic
vasculature (without sequelae) during attempted removal of
the delivery system from the body; the articulated stent was
successfully retrieved .
Other than stent emhnlization, serious complications
were limited largely to hemorrhagic events related to ag-
gressive anticoagulant therapy daring the posrstent period .
These consisted of one retroperitoneal hemorrhage, one
large groin hematoma and four false aneurysms that required
surgical repair under local anesthesia . The hemorrhagic
complication rate tended to be greater (5 [25%) of 2 ) in the
patients receiving warfarin compared with those receiving
only aspirin and dipyridamole alone (1 [7%] of 15), although
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Figure 3. Caliper analysis of acute results. A . Absolute luminal
diameters (mm) of the 35 successful scent placements are shown
before (pre) (
and after (post) ( ) balloon angioplasty (PICA) .
and poststent placement 1 1 . B . The equivalent diameter stenoses
M . In both panels, patients are shown in ascending order of
reference segment (A) diameter,
this difference did not reach statistical significance . There
were no abrupt closures in the catheterization laboratory and
no patient required emergency bypass surgery . One patient
(3%) developed subacute scent thrombosis on day 8 after
stent placement, after mistaken discontinuation of warfarin
therapy . This vessel was reopened by combination throm-
Figure 4. Improvement in suboptimal bal-
loon angioplasty result by stem placement.
A complex proximal lesion is shown before
(upper lel) and after (k center) conven-
tional dilation, resulting in a prominent dis-
section involving the top and bottom stir-
faces of the vessel (arrow) . After scent
placement (right center), the lumen appears
normal (arrow) . Follow-op angicgraptty at 6
months (upper right) demonstrates only
mild focal intimal hyperpiasia (maximal in-
timal thickness .55 mm, stenosis 22%) ad-
jacent to the sinus node artery . At the time
of
restudy, restenosis (lower left) was noted
in a distal lesion that had been treated by
conventional angioplasty at the time of
ini-
tial stent placement . This lesion was man-
aged by placement of a single articulated
stent (lower right, arrows) .
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bolytic therapy and repeat dilation. The mean total serum
creatine kinase (CK) for the entire group was 73 ± 59 IU on
the day after implantation, and plasma MB CK was not
elevated 1>1 111) in any patient .
Acute a raphie
results-
Caliper analysis in the 35
patients with successful stem placement (Fig. 3) revealed a
baseline stenosis diameter of .59 ± .56 mm, which was
increased to 1 .91 ± .64 mm by conventional balloon angio-
plasty and to 3.28 t .35 mm after scent placement (p <
. 1) . Relative to the reference diameter of 3.25 ± .52 mm,
this corresponded to a diameter stenosis of 83 ± 14% at
baseline study, 42 ± 14% after conventional angioplasty and
-3 ± 12% after stent placement.
Qualitative analysis showed that 18 454%) of the 35
patients in this preselected high risk group had a suboptimal
angiographic result after conventional angioplasty : 5 patients
(14%) had evident luminal haziness or irregularity, 9 patients
(26%) had moderate local dissection and 4 patients (14%) had
severe or extensive dissection, or both. Stent placement
improved these findings in 9 of the 14 patients, resulting in a
completely smooth lumen in 6 of these 9 patients (Fig. 4).
The remaining five patients still had a short segment of
unstented disease or dissection distal to the stem .
Follow-up results. Only 2 patients developed recurrent
angina or had evidence of reversible ischemia on thallium
exercise testing, but routine 4 to 6 month follow-up angiog-
raphy in 25 patients disclosed restenosis in 7 (2891) . This
group included 4 (57%) of
the 7 patients with multiple stems,
but only 3 (17 %) of the 13 patients with a single stem (p <
. 5).
Angiography in one patient showed a widely patent stent,
but the film was unavailable for caliper measurement . Cali-
per analysis of follow-up angiogmms (Fig. 5) in 17 other
patients without restenosis showed a minimal luminal diam-
eter of 2.38 ±
.58 mm and an average luminal diameter of
336
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Figure 5. Caliper analysis of follow-up angiograms . A. Maximal
diameter stenosis (%) is shown far the 18 patients without res(enosis
and the 5 patients with restenosis. The diameter stenosis present
immediately after stent placement is shown for reference
.
B. Calcu-
lated maximal intimal hyperplasia (mm) is shown for patients
without and with restenosis. In both panels, patients are shown in
descending order of luminal diameter at the 4 to 6 month restudy,
and the small filled boxes represent multiple stents .
2
.93
.
.54 mm within the scented segment. These measure-
ments corresponded to a maximal focal stenosis of 29 ± 15%
relative to the adjacent reference segment . The reduction in
stent lumen in these patients represented a maximal focal
neointimal thickness of
.68 ± .26 mm, against a back-
ground of a generalized neointimal thickness of .4 ± .24
mm within the stent (approximately
. 8 mm of which is due
to the wall thickness of the scent itself).
By contrast, the seven
patients with in-stem restenosis
(Fig. 5) had a minimal luminal diameter of .55 ± .49 mm.
This corresponded to a diameter stenosis of 83 m 14%
relative to the reference segment and to a maximal neointi-
mal thickness of 1 .44 ±
.36 mm within the stent . In two
patients, this process involved the entire stem (Fig . 6), but in
four others, it consisted of focal hyperplasia within a mildly
narrowed scent (in two patients at the stem articulation (Fig .
7) and in two at the junction of the scent with a diseased but
unstented vessel).
Of the seven patients with restenosis, one had asympto-
matic late total occlusion of four stents placed for extensive
dissection after balloon angioplasty and was managed med-
ically ; the remaining six patients with in-stent restenosis
JACC Val. 16. No. 2
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Figure 6. Diffuse restenosis within tandem stents placed for total
occlusion. Tandem stents were placed with some overlap (upper
left, arrows) as treatment for a lengthy total occlusion . At 5 month
restudy (upper center and lower left), them is marked diffuse
restenosis (92%) due to diffuse intimal hyperplasia (1 .51 mm) within
the metallic stem shadow (small arrows)
. This lesion was easily
dilated (upper and lower righ) .
underwent redilation within the stem, reducing the maximal
stenosis from 8 ± 12% to 13 ± 21% compared with the
reference artery (Fig. 6 and 7) . Only one of these recitations
was associated with an angiographically evident local dis-
section. One additional patient developed restenosis of a
distal lesion that had been treated by conventional angio-
plasty at the time of proximal stent placement . This distal
restenosis was then treated by placement of a single articu-
lated stem during the restudy procedure (Fig . 4).
Discussion
Previous experience with coronary stems. Despite major
strides in coronary angioplasty equipment and technique,
with concomitant improvement in procedural success (to
>9 %) and a reduction in the incidence of emergency bypass
surgery (to <3%), conventional balloon dilation continues to
have difficulty in dilating eccentric elastic lesions, prevent-
ing or reversing significant dissection and reducing the 3 %
incidence rate of proliferative restenosis (5,6) . One major
goal for the "new technology" angioplasty devices (atherec-
tomy, laser or stent) is control of these residual problems
. At
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Figure 7. Focal restenosis at stent articula-
tion site. Articulated scent (left panel) dem .
onstrates a small gap (open arrow) at the
articulation site between the two rigid seg-
ments (dark arrows). Contrast injection
(middle panel) reveals that this is the site of
focal restenosis (arrow) (maximal intimal
hyperplasia of 1 .27 mm, stenosis 88%)
within an otherwise uninvolved stent (gen-
eralized intimal hyperplasia .38 mml. The
focal lesion was easily redilated (right panel)
.
this time, however, all three classes of device are still
undergoing preliminary clinical feasibility testing as investi-
gational devices (1) . The concept of intravascular stenting is
nearly as old as that of transluminal recanalization (7) . but all
stems face three major hurdles : I) successful placement, 2)
avoidance of thrombotic occlusion, and 3) prompt coverage
by a thin but functional neointima. Early efforts (2 .3) to use
metallic coils of various designs proved unsatisfactory be-
cause of difficult placement, thrombosis and late occlusion
by intimal hyperplasia .
Recently, Sigwart ct al . (8) reported more satisfactory
results with the Medivent scent (a self-expanding mesh of 16
to 24 steel filaments, each . 8 mm in diameter). This device
can be delivered reliably into the coronary circulation and
has been used successfully in Europe (8) in eccentric or
complex lesions and for reversal of abrupt closure . Roubin et
al . (9) described a balloon-expandable, serpentine steel coil
scent (wire diameter .15 mm), that has been used to
successfully reverse rt rupt closure in >25 patients (2 .3) .
The balloon-expandable stent used in the current study is
a modification of the slotted tube design developed by
Palmaz et al . (1 ) . Extensive experience (11) with this design
has been gained in the peripheral circulation . where it
provides excellent short-term results and long-term patency .
Coronary artery trials (2) . however, began only in December
1987 . The experience in this report thus involves early
experience, although it is part ofa multicenter study (12) that
now includes >2 patients.
Successful stmt placement . Although less problematic
than the original rigid design, the more flexible articulated
design still poses difficulties in placement (13) because the
stent (mounted on the surface of the balloon) may snag on
diseased or dissected coronary lining before reaching its
desired destination. This is compounded by poor stmt
radiopacity (making precise tandem placement difficult) and
by the potential for !he stem to detach from the delivery
balloon and embolize during unsuccessful delivery . These
LEVINE Er AL .
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problems should be controlled by the introduction of a
sheathed delivery system now under development.
Acute angiographic results
. Both qualitative and digital
caliper assessments show that successful stent placement
improves the initial angiographic result compared with that
of balloon dilation alone . This statement must be tempered
by the fact that we used a larger average balloon size (3 .5 ±
.4 mm) after stent deployment than was used for the
prestent dilation (3 .1 ± .4 mm), but the increase in luminal
diameter after stent placement (1.91 ± .64 to 3 .28 ± .35
mm) was significantly more than would be expected on the
basis of this comparatively small difference in balloon size
alone. Stent placement reduced lesion stenosis to -3%
(compared with 42% after conventional balloon dilation),
regardless of baseline lesion eccentricity or complexity .
Similar immediate angiographic findings have been reported
(14) for the Medinvent device .
Thrmbotic occlusion. With the regimen of heparin, dex-
tran . aspiri i and dipyridamote. there were no cases of acute
thrombosis . Although animal studies with this device sug-
gested that aspirin and dipyridamole should suffice as long-
term therapy (unless unstented distal disease or dissection is
present), initial experience (15) showed an unacceptably
high (15%) incidence rate of subacute stent thrombosis
within the first 7 to 1 days after stent placement, which has
been reduced (to <I%) by the addition of warfarin to aspirin
and dipyridamole. We had only one patient (3%) with
subacute stent thrombosis, which occurred in the setting of
two steels. unstented distal disease and warfarin discontin-
uation . The patient's thrombotic occlusion was successfully
reopened, but she then developed late symptomatic resteno-
sis requiring repeat dilation . Although the regimen of unin-
terrupted heparin and warfarin anticoagulant therapy that
was used in the latter part of our series may have prevented
subacute scent thrombosis, it also tended to be associated
with more local vascular complications .
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Late restenosis. The overall 4 to 6 month angiographic
restenosis rate of 28% does not appear to be significantly
different from that usually associated with conventional
angioplasty (6). However, restenosis occurred predomi-
nantly in patients with multiple stems that, when placed in
tandem with significant overlap, increase the surface density
of metal within the vessel . Animal studies
(2)
suggest that
greater metal surface area increases local thrombus deposi-
tion, possibly contributing to the high (57%) incidence rate of
patients with late restenosis after a multiple stem procedure
(Fig . 8). In contrast, the restenosis rate for a single stent
procedure was only 17% Restenosis was diffuse but moder-
ate in one patient . confined to the stent articulation site in
one patient and occurred at the junction of the stem and the
diseased distal artery in one patient . If confirmed by addi-
tional patients . this low incidence rate of restenosis after a
single stent procedure would constitute hopeful evidence
that altering the type of lesion treatment may help to control
this limitation of balloon angioplasty .
The thickness of the neointimal layer within even those
stems free of restenosis averaged .4 to 68 mm, which is
substantially thicker than the 5 to 1 pm ( . 5 to .1 mm)
of intimm hvperplasia seen with this device in long-term
implantation in rabbit aorta or dog coronary artery (11,16) . It
was, however, more typical of the 7 to 5 µm ( .2 to .5
mm) of neointimal thickness reported with other stems
(8,9,17) . Because the observed intimal hyperplasia caused
some narrowing of the lumen (to 29 t 15% diameter steno.
sis), it may he viewed as a "pathologic" process rather than
simply a "physiologic" response that serves to correct the
slight short-term overdilation of the stent relative to the
adjacent reference segment
. This suggests that additional
research is needed on surface or systemic pharmacotherapv
to decrease acute thrombus deposition and late intimal
proliferation within coronary endoprosthesec
Interestingly
. five of six in slept restennsef that were
subjected to repent balloon dilation
did To with excellent
(<2
% residual rlenosis) short-term results . At 4 to 6
months, the scent is firmly incorporated into the vessel wall
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Figure It. Moderate inrimat hyperptasia at
the point of overlap between tandem stems.
Baseline angiogram shows lien to right) ex-
tensive disease in restenotic lesion before
(arrows) and after conventional balloon an-
gioplasty and after placement of tandem
struts (kit renter and right center). At 6
month restudy (far right), mild focal disease
(arrow) is present at the scent overlap site
.
Calculated maximal intimal thickness is
.76
mm at this site compared with generalized
intimal hyperplasia of
.16 mm throughout
the rest of the stented segment . This is not
restenosis because the resulting diameter
stenosis is only 32%.
and can be expanded further (up to 5 mm) during repeat
dilation, affording the artery a unique plastic rather than
elastic behavior. The generally smooth appearance of the
lumen after redilation suggests that the hypertraphic neoint-
ima may often be able to stretch rather than fracture, but
additional data are needed to determine whether such "sec-
ondary" dilations have a favorable or unfavorable long-term
prognosis.
Limitations . This study has several important limitations
.
1) As with all "new technology" angioplasty device trials,
the current study is subject to the limitations associated with
learning a new technique, utilizing prototype equipment and
generating a comparatively small sample size . 2) Because of
institutional preferences, we limited our placement attempts
to the right coronary artery, whereas others (13) have placed
this stent successfully in other native vessels . Our selection
of right coronary artery lesions may have allowed more
favorable results than would a more diverse series that
included lesions at higher risk for restenosis (for example,
proximal left anterior descending artery or vein graft le-
sions). 3) We relied on digital caliper measurements rather
than computer-aided edge detection or videodensitometry
for our quantitative angiography . Caliper measurements,
however, have been shown (4) to be virtually as accurate
as the more sophisticated techniques, particularly in mea-
suring the round smooth lumen seen after stent placement .
4) Even with computer techniques, analyses such as those of
neointimal thickness (which are based on identification of
the faint metallic scent shadow) are difficult, although filming
before contrast injection provided images suitable for mea-
surement of all of the right coronary artery stems in this
series . 5) The angiographic definition of restenosis as >6 %%
narrowing in an asymptomatic patient is arguable, and use of
a higher or lower degree of absolute stenosis to define
restenosis in asymptomatic patients would have yielded
slightly higher or lower restenosis rates (Fig . 5A). An ab-
solute percent stenosis definition, however, is preferable to
definitions comparing the late result with the immediate
poststent appearance (6)
.
Such definitions were devised for
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conventional balloon angioplasty, which typically reduces
the diameter stenosis to 3 to 4 from 5 % to 9 %o . so
that loss of half the gain, or an increase in absolute stenosis
by >3 c, would result
:
: a stenosis >7 . With a postpro-
cedure stenosis rate close to %, however, a stent could
undergo such changes and still maintain a <5 % stenosis.
6) Even a favorable appearance at
4
to
6
months after stent
placement does not necessarily guarantee longer-term sta-
bility
of the result. Animal studies 12,16)
. however, suggest
that neointimal thickness is maximal at I to 2 months after
stent placement, with subsequent attenuation as the early
fibrocellular process matures into a thin collagenous mem-
brane.
Conclusions
. Our early experience with the Schatz-
Palmaz balloon-expandable coronary stint suggests that
successful placement is possible in carefully selected ana-
tomic situations and that stent placement producas addi-
tional qualitative and quantitative improvements in stenosis
geometry after conventional balloon dilation . No acute
thrombosis occurred and subacute thrombosis was limited to
one patient with multiple scents after self-discontinuation of
warfarin on hospital discharge. Restenosis was predomi-
nantly asymptomatic as a result of preselection of patients
with angiographically evident collateral vessels. Because
restenosis was common in patients who received multiple
stents, lesions >15 mm should probably not be considered
for treatment with the current device . Patients treated with a
single scent, however, had a favorable angiograp tic resteno-
sis rate of 17%
. This
device may be of potential 'alue as an
adjunctive aid to conventional balloon dilation .
We recognize Richard Schatz, MD for his participation in two of the study
procedures. We also thank Lisa Hausmann and cashererization laboratory
technicians Patrice McGregor and Sharon ultra fm their ongoing assistance in
this project.
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